Evidence map›Paper›PMID 35049960›Full record

ArticleJournal of fungi (Basel, Switzerland)2021

María Soledad Miró, Juan Pablo Caeiro, Emilse Rodriguez, Lara Vargas, Cecilia Vigezzi, Paula A Icely, Graciela D V Castillo, Ana I Azcurra, Claudio D Abiega, Fernando O Riera and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 18 citations in OpenAlex.

  1. Biphasic Regulation of Epithelial Antimicrobial Peptides DuringJournal of fungi (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Anti-Microorganisms · 2023
    Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

María Soledad MiróLaboratory of Innate Immunity to Fungal Pathogens, Department of Clinical Biochemistry, Faculty of Chemical Sciences, National University of Córdoba, Córdoba 5000, Argentina.
Juan Pablo CaeiroInfectious Disease Section, Hospital Privado Universitario de Córdoba, Córdoba 5000, Argentina.ORCID 0000-0001-6172-1395
Emilse RodriguezLaboratory of Innate Immunity to Fungal Pathogens, Department of Clinical Biochemistry, Faculty of Chemical Sciences, National University of Córdoba, Córdoba 5000, Argentina.
Lara VargasInfectology Department, Sanatorio Allende, Córdoba 5000, Argentina.
Cecilia VigezziLaboratory of Innate Immunity to Fungal Pathogens, Department of Clinical Biochemistry, Faculty of Chemical Sciences, National University of Córdoba, Córdoba 5000, Argentina.
Paula A IcelyLaboratory of Innate Immunity to Fungal Pathogens, Department of Clinical Biochemistry, Faculty of Chemical Sciences, National University of Córdoba, Córdoba 5000, Argentina.
Graciela D V CastilloDepartment of Buccal Biology, Faculty of Odontology, National University of Córdoba, Córdoba 5000, Argentina.
Ana I AzcurraDepartment of Buccal Biology, Faculty of Odontology, National University of Córdoba, Córdoba 5000, Argentina.
Claudio D AbiegaInfectious Disease Section, Hospital Privado Universitario de Córdoba, Córdoba 5000, Argentina.
Fernando O RieraInfectology Department, Sanatorio Allende, Córdoba 5000, Argentina.
Claudia E SotomayorLaboratory of Innate Immunity to Fungal Pathogens, Department of Clinical Biochemistry, Faculty of Chemical Sciences, National University of Córdoba, Córdoba 5000, Argentina.
Universidad Nacional de Córdoba · ARFundacion Allende · ARHospital Privado · AR

Funding

Agencia Nacional de Promoción Científica y Tecnológica PICT-2019-2012Consejo Nacional de Promoción Científica y Tecnológica, CONICET, Argentina PIP-112 201501-00652COSecretaria de Ciencia y Técnica, Universidad nacional de Córdoba, SECYT-UNC 30720150100934CB
6 · The paper itself

Abstract

Vulvovaginal candidiasis (VVC) and recurrent vulvovaginal candidiasis (RVVC) are two forms of a disease caused by

Indexed as

antimicrobial peptidesbeta-defensinCandida albicanscytokinesfungal immunityhBD1mBD1vaginitisvulvovaginal candidiasis

Identifiers

PMID35049960
PMCPMC8778459
OpenAlexW4200589207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.